Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shan-Lu Liu

Showing results (121-130 of 140) with videos related to

Pageof 14
Sort By:
Journal of Virology|August 11, 2021
A Methyltransferase-Defective Vesicular Stomatitis Virus-Based SARS-CoV-2 Vaccine Candidate Provides Complete Protection against SARS-CoV-2 Infection in HamstersMijia Lu, Yuexiu Zhang, Piyush Dravid, et al.
Nature Communications|August 19, 2025
O-GlcNAc transferase plays dual antiviral roles by integrating innate immunity and lipid metabolismHong Dong, Chenxi Liang, Junjie Zhang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2023
Prime-Pull Immunization of Mice with a BcfA-Adjuvanted Vaccine Elicits Sustained Mucosal Immunity That Prevents SARS-CoV-2 Infection and PathologyMohamed M Shamseldin, Adam Kenney, Ashley Zani, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 6, 2025
Intranasal measles virus- and mumps virus-based SARS-CoV-2 vaccine candidates prevent SARS-CoV-2 infection and transmissionCheng Chih Hsu, Michelle Chamblee, Chengjin Ye, et al.
Nature Communications|July 3, 2024
Three SARS-CoV-2 spike protein variants delivered intranasally by measles and mumps vaccines are broadly protectiveYuexiu Zhang, Michelle Chamblee, Jiayu Xu, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 10, 2021
A safe and highly efficacious measles virus-based vaccine expressing SARS-CoV-2 stabilized prefusion spikeMijia Lu, Piyush Dravid, Yuexiu Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2023
A next-generation intranasal trivalent MMS vaccine induces durable and broad protection against SARS-CoV-2 variants of concernJiayu Xu, Yuexiu Zhang, Panke Qu, et al.
Nucleic Acids Research|September 13, 2011
Biochemical, inhibition and inhibitor resistance studies of xenotropic murine leukemia virus-related virus reverse transcriptaseTanyaradzwa P Ndongwe, Adeyemi O Adedeji, Eleftherios Michailidis, et al.
Medrxiv : the Preprint Server for Health Sciences|August 31, 2021
TREATMENT WITH SOLUBLE CD24 ATTENUATES COVID-19-ASSOCIATED SYSTEMIC IMMUNOPATHOLOGYNo-Joon Song, Carter Allen, Anna E Vilgelm, et al.
Journal of Hematology & Oncology|January 11, 2022
Treatment with soluble CD24 attenuates COVID-19-associated systemic immunopathologyNo-Joon Song, Carter Allen, Anna E Vilgelm, et al.
Pageof 14

Showing results (121-130 of 140) with videos related to

Sort By:
Pageof 14
Journal of Virology|August 11, 2021
A Methyltransferase-Defective Vesicular Stomatitis Virus-Based SARS-CoV-2 Vaccine Candidate Provides Complete Protection against SARS-CoV-2 Infection in HamstersMijia Lu, Yuexiu Zhang, Piyush Dravid, et al.
Nature Communications|August 19, 2025
O-GlcNAc transferase plays dual antiviral roles by integrating innate immunity and lipid metabolismHong Dong, Chenxi Liang, Junjie Zhang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2023
Prime-Pull Immunization of Mice with a BcfA-Adjuvanted Vaccine Elicits Sustained Mucosal Immunity That Prevents SARS-CoV-2 Infection and PathologyMohamed M Shamseldin, Adam Kenney, Ashley Zani, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 6, 2025
Intranasal measles virus- and mumps virus-based SARS-CoV-2 vaccine candidates prevent SARS-CoV-2 infection and transmissionCheng Chih Hsu, Michelle Chamblee, Chengjin Ye, et al.
Nature Communications|July 3, 2024
Three SARS-CoV-2 spike protein variants delivered intranasally by measles and mumps vaccines are broadly protectiveYuexiu Zhang, Michelle Chamblee, Jiayu Xu, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 10, 2021
A safe and highly efficacious measles virus-based vaccine expressing SARS-CoV-2 stabilized prefusion spikeMijia Lu, Piyush Dravid, Yuexiu Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2023
A next-generation intranasal trivalent MMS vaccine induces durable and broad protection against SARS-CoV-2 variants of concernJiayu Xu, Yuexiu Zhang, Panke Qu, et al.
Nucleic Acids Research|September 13, 2011
Biochemical, inhibition and inhibitor resistance studies of xenotropic murine leukemia virus-related virus reverse transcriptaseTanyaradzwa P Ndongwe, Adeyemi O Adedeji, Eleftherios Michailidis, et al.
Medrxiv : the Preprint Server for Health Sciences|August 31, 2021
TREATMENT WITH SOLUBLE CD24 ATTENUATES COVID-19-ASSOCIATED SYSTEMIC IMMUNOPATHOLOGYNo-Joon Song, Carter Allen, Anna E Vilgelm, et al.
Journal of Hematology & Oncology|January 11, 2022
Treatment with soluble CD24 attenuates COVID-19-associated systemic immunopathologyNo-Joon Song, Carter Allen, Anna E Vilgelm, et al.
Pageof 14